-Bloomberg
Profounda Reports FDA Granted Co. Orphan Drug Designation Approval For Treatment Of Invasive Candidiasis With Miltefosine; BZ NOTE: Co. Licensed Miltefosine From Knight Therapeutics In 2013
- Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. and is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body.
- In the United